Biohaven Pharmaceutical Holding Company Ltd BHVN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/01/22 EDT
145.31UNCH (UNCH)
Volume
7,658
Close
145.31quote price arrow down-0.40 (-0.27%)
Volume
865,764
52 week range
79.01 - 151.51
Loading...
  • Open145.44
  • Day High145.92
  • Day Low145.10
  • Prev Close145.71
  • 52 Week High151.51
  • 52 Week High Date10/05/21
  • 52 Week Low79.01
  • 52 Week Low Date04/29/22

Key Stats

  • Market Cap10.323B
  • Shares Out71.04M
  • 10 Day Average Volume1.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.10
  • YTD % Change5.44

KEY STATS

  • Open145.44
  • Day High145.92
  • Day Low145.10
  • Prev Close145.71
  • 52 Week High151.51
  • 52 Week High Date10/05/21
  • 52 Week Low79.01
  • 52 Week Low Date04/29/22
  • Market Cap10.323B
  • Shares Out71.04M
  • 10 Day Average Volume1.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.10
  • YTD % Change5.44

RATIOS/PROFITABILITY

  • EPS (TTM)-11.85
  • P/E (TTM)-12.27
  • Fwd P/E (NTM)-15.05
  • EBITDA (TTM)-497.923M
  • ROE (TTM)-805.56%
  • Revenue (TTM)737.54M
  • Gross Margin (TTM)85.74%
  • Net Margin (TTM)-94.91%
  • Debt To Equity (MRQ)-254.19%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biohaven Pharmaceutical Holding Company Ltd. is a commercial-stage biopharmaceutical company. The Company has a portfolio of therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. The Company's Neuroinnovation portfolio includes NURTEC ODT (rimegepant) for the acute and preventive treatment of migraine and a pipeline of product candidates across five platforms: calcitonin gene related peptide (CGRP)...
Vlad Coric M.D.
Chairman of the Board, Chief Executive Officer
Matthew Buten
Chief Financial Officer
Address
215 Church St
New Haven, CT
06510-1803
United States

Top Peers

SYMBOLLASTCHG%CHG
NBIX
Neurocrine Biosciences Inc
99.25+1.77+1.82%
NVCR
Novocure Ltd
73.30+3.80+5.47%
MRVI
Maravai LifeSciences Holdings Inc
29.40+0.99+3.48%
SRPT
Sarepta Therapeutics Inc
75.71+0.75+1.00%
HALO
Halozyme Therapeutics Inc
44.48+0.48+1.09%